As of 2025-05-27, the EV/EBITDA ratio of Parenteral Drugs (India) Ltd (PDPL.NS) is
3.11.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PDPL.NS's latest enterprise value
is 1,158.47 mil INR. PDPL.NS's TTM EBITDA according to its financial statements is
372.69 mil INR. Dividing these 2
quantities gives us the above PDPL.NS EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
8.3x - 10.3x |
9.2x |
| Forward P/E multiples |
8.3x - 9.3x |
8.6x |
| Fair Price |
67.78 - 93.28 |
75.60 |
| Upside |
2237.4% - 3116.6% |
2506.8% |